We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
BioNTech
BNTX
$21.9B
| $43.1M | 0.05% |
463,163
+369,708
| +396% | +$34.8M |
2025 Q4
2 quarters
|
|
402
Somnigroup International
SGI
$14.5B
| $43M | 0.05% |
549,036
+355,309
| +183% | +$26M |
2024 Q4
6 quarters
|
|
403
CALL
State Street SPDR S&P Bank ETF
KBE
$1.45B
| $42.7M | 0.05% |
+626,200
| New | +$40.1M |
2026 Q2
0 quarters
|
|
404
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $42.6M | 0.05% |
200,000
+79,300
| +66% | +$16.2M |
2025 Q4
2 quarters
|
|
405
Madrigal Pharmaceuticals
MDGL
$10.2B
| $42.4M | 0.05% |
+79,011
| New | +$40.5M |
2026 Q2
0 quarters
|
|
406
Definium Therapeutics
DFTX
$4.98B
| $42.2M | 0.05% |
897,658
-376,563
| -30% | -$9.31M |
2025 Q4
2 quarters
|
|
407
Public Service Enterprise Group
PEG
$36.3B
| $42.1M | 0.05% |
518,442
+510,458
| +6,394% | +$40.8M |
2024 Q1
9 quarters
|
|
|
408
CALL
Meta Platforms (Facebook)
META
$1.59T
| $41.9M | 0.05% |
74,400
-414,500
| -85% | -$253M |
2022 Q3
15 quarters
|
|
409
Ulta Beauty
ULTA
$26.8B
| $41.9M | 0.05% |
92,861
+74,130
| +396% | +$37.6M |
2024 Q3
7 quarters
|
|
410
PUT
Wells Fargo
WFC
$248B
| $41.7M | 0.05% |
504,700
+2,400
| +0.5% | +$193K |
2022 Q1
17 quarters
|
|
411
Linde
LIN
$234B
| $41.5M | 0.05% |
79,911
+70,950
| +792% | +$35.9M |
2021 Q4
18 quarters
|
|
412
Modine Manufacturing
MOD
$7.26B
| $41.4M | 0.05% |
155,079
-111,034
| -42% | -$29.3M |
2025 Q2
4 quarters
|
|
413
Duke Energy
DUK
$97.3B
| $41.4M | 0.05% |
326,944
+315,110
| +2,663% | +$39.7M |
2024 Q2
8 quarters
|
|
414
Edwards Lifesciences
EW
$52.3B
| $41.3M | 0.05% |
456,202
+446,204
| +4,463% | +$37.4M |
2022 Q4
14 quarters
|
|
415
Jefferies Financial Group
JEF
$10.6B
| $41M | 0.05% |
820,771
+292,187
| +55% | +$15.1M |
2023 Q2
12 quarters
|
|
416
Comcast
CMCSA
$77.6B
| $40.9M | 0.05% |
1,664,267
+1,610,707
| +3,007% | +$41.6M |
2023 Q1
13 quarters
|
|
417
CALL
Alibaba
BABA
$249B
| $40.2M | 0.05% |
419,200
+121,000
| +41% | +$15.2M |
2023 Q3
11 quarters
|
|
418
PUT
Micron Technology
MU
$1.05T
| $40.2M | 0.05% |
34,800
-113,200
| -76% | -$84.9M |
2021 Q4
18 quarters
|
|
419
Sysco
SYY
$40.5B
| $40.1M | 0.05% |
480,008
-799,614
| -62% | -$60.5M |
2024 Q2
8 quarters
|
|
420
Gartner
IT
$14B
| $40M | 0.05% |
308,288
+299,314
| +3,335% | +$45.1M |
2025 Q3
3 quarters
|
|
421
Teleflex
TFX
$5.89B
| $40M | 0.05% |
315,212
-86,205
| -21% | -$11M |
2025 Q4
2 quarters
|
|
422
CALL
Rivian
RIVN
$17.1B
| $39.8M | 0.05% |
2,294,300
+63,600
| +3% | +$992K |
2024 Q3
7 quarters
|
|
423
Alcoa
AA
$10.5B
| $39.5M | 0.05% |
757,389
+671,178
| +779% | +$44.9M |
2026 Q1
1 quarter
|
|
424
PUT
Charles Schwab
SCHW
$154B
| $39.4M | 0.05% |
427,300
-51,800
| -11% | -$4.72M |
2021 Q4
18 quarters
|
|
425
Venture Global Inc
VG
$34.5B
| $39.4M | 0.05% |
3,540,269
+3,496,567
| +8,001% | +$44.2M |
2025 Q1
5 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.